Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kahn

Showing results (111-120 of 1,623) with videos related to

Pageof 163
Sort By:
Expert Opinion on Pharmacotherapy|October 5, 2001
Oral contraceptives and moodL S Kahn, U Halbreich
Journal of Psychiatric Practice|June 30, 2005
Hyperprolactinemia and schizophrenia: mechanisms and clinical aspectsUriel Halbreich, Linda S Kahn
Psychopharmacology|January 1, 1993
Serotonin, dopamine and their interactions in schizophreniaR S Kahn, M Davidson
American Family Physician|July 1, 1983
Contact dermatitis due to self-medicationN J Fiumara, S Kahn
M.D. Computing : Computers in Medical Practice|March 1, 1994
Dr. Welford's chart notesG S Kahn, T Lynch
Medicina (Kaunas, Lithuania)|July 13, 2019
Suicide in Schizophrenia: An Educational OverviewLeo Sher, René S Kahn
Molecular Psychiatry|April 28, 2026
Cognitive impairment preceding the onset of the first psychosis episode in schizophreniaAbraham Reichenberg, René S Kahn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2001
Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trialsA Aleman, R S Kahn
Psychosomatic Medicine|May 31, 2001
Are women with premenstrual dysphoric disorder prone to osteoporosis?U Halbreich, L S Kahn
Psychoneuroendocrinology|March 26, 2003
Hormonal aspects of schizophrenias: an overviewU Halbreich, L S Kahn
Pageof 163

Showing results (111-120 of 1,623) with videos related to

Sort By:
Pageof 163
Expert Opinion on Pharmacotherapy|October 5, 2001
Oral contraceptives and moodL S Kahn, U Halbreich
Journal of Psychiatric Practice|June 30, 2005
Hyperprolactinemia and schizophrenia: mechanisms and clinical aspectsUriel Halbreich, Linda S Kahn
Psychopharmacology|January 1, 1993
Serotonin, dopamine and their interactions in schizophreniaR S Kahn, M Davidson
American Family Physician|July 1, 1983
Contact dermatitis due to self-medicationN J Fiumara, S Kahn
M.D. Computing : Computers in Medical Practice|March 1, 1994
Dr. Welford's chart notesG S Kahn, T Lynch
Medicina (Kaunas, Lithuania)|July 13, 2019
Suicide in Schizophrenia: An Educational OverviewLeo Sher, René S Kahn
Molecular Psychiatry|April 28, 2026
Cognitive impairment preceding the onset of the first psychosis episode in schizophreniaAbraham Reichenberg, René S Kahn
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2001
Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trialsA Aleman, R S Kahn
Psychosomatic Medicine|May 31, 2001
Are women with premenstrual dysphoric disorder prone to osteoporosis?U Halbreich, L S Kahn
Psychoneuroendocrinology|March 26, 2003
Hormonal aspects of schizophrenias: an overviewU Halbreich, L S Kahn
Pageof 163